MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 -
Germany
This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
German
Profile: MII PR Onkologie Therapieempfehlung Kombinationstherapie version: 2027.0.0-ballot.1
status: Active
intent: Proposal
code: Chemotherapie
subject: Martin Beispiel Male, DoB: 1958-11-03
authoredOn: 2024-03-05
reasonReference: Condition Bösartige Neubildung: Colon ascendens
action
title: FOLFOX4 Protocol
description: FOLFOX4 chemotherapy protocol: Fluorouracil + Folinsäure + Oxaliplatin, 12 cycles planned
code: FOLFOX4
Actions
Title Description Resource Fluorouracil (5-FU) 5-Fluorouracil - pyrimidine analog MedicationRequest: status = completed; intent = proposal; medication[x] = Fluorouracil; authoredOn = 2024-03-05; note = Completed as planned for all 12 cycles Folinsäure (Leucovorin) Folinic acid - enhances 5-FU efficacy MedicationRequest: status = completed; intent = proposal; medication[x] = Calciumfolinat; authoredOn = 2024-03-05; note = Completed as planned for all 12 cycles Oxaliplatin Platinum-based chemotherapy agent MedicationRequest: status = stopped; statusReason = Adverse reaction (disorder); intent = proposal; medication[x] = Oxaliplatin; authoredOn = 2024-03-05; note = Administered for cycles 1-6 only. Stopped due to cumulative neurotoxicity.